INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 216 filers reported holding INARI MED INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $884,000 | -93.4% | 9,688 | -94.2% | 0.01% | -94.3% |
Q3 2021 | $13,476,000 | -1.4% | 166,165 | +13.4% | 0.09% | -8.4% |
Q2 2021 | $13,673,000 | +10.8% | 146,577 | +27.1% | 0.10% | +5.6% |
Q1 2021 | $12,336,000 | +820.6% | 115,291 | +651.1% | 0.09% | +718.2% |
Q4 2020 | $1,340,000 | – | 15,349 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Affinity Asset Advisors, LLC | 125,000 | $11,409,000 | 4.14% |
SECTORAL ASSET MANAGEMENT INC | 163,550 | $14,927,000 | 2.25% |
Lisanti Capital Growth, LLC | 81,460 | $7,435,000 | 1.08% |
Pier Capital, LLC | 99,422 | $9,074,000 | 0.96% |
Beck Bode, LLC | 33,384 | $3,047,000 | 0.76% |
Nicholas Investment Partners, LP | 104,932 | $9,577,000 | 0.61% |
CNA FINANCIAL CORP | 24,773 | $2,261,000 | 0.59% |
NEXT CENTURY GROWTH INVESTORS LLC | 56,523 | $5,158,000 | 0.46% |
HARBOURVEST PARTNERS LLC | 38,540 | $3,518,000 | 0.45% |
Birchview Capital, LP | 7,000 | $639,000 | 0.41% |